KARLEE VAN DAM: Open Payments
NPI 1972154185 · BENTONVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 16 payments from 8 companies in 2025. Trend: 2023 $1,107 · 2024 $1,223 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $65 |
| Lilly USA, LLC | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| ABBVIE INC. | 3 | $46 |
| PFIZER INC. | 2 | $37 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: DUPIXENT, TALTZ, Sotyktu, CIBINQO, SKYRIZI, Zoryve, LIBTAYO, SPEVIGO.
Industry payments across AR — which companies pay providers there.
